ABN AMRO Bank N.V. Acquires 193,782 Shares of Stryker Corporation $SYK

ABN AMRO Bank N.V. lifted its holdings in shares of Stryker Corporation (NYSE:SYK) by 40.4% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 673,936 shares of the medical technology company’s stock after purchasing an additional 193,782 shares during the period. Stryker accounts for about 2.4% of ABN AMRO Bank N.V.’s portfolio, making the stock its 10th biggest position. ABN AMRO Bank N.V. owned 0.18% of Stryker worth $248,203,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Mid American Wealth Advisory Group Inc. bought a new position in Stryker during the second quarter worth $26,000. Clayton Financial Group LLC acquired a new position in shares of Stryker during the third quarter valued at about $26,000. Elevation Point Wealth Partners LLC bought a new position in shares of Stryker during the 2nd quarter worth about $28,000. Sachetta LLC boosted its position in shares of Stryker by 58.7% during the 2nd quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock worth $29,000 after purchasing an additional 27 shares in the last quarter. Finally, Kilter Group LLC acquired a new stake in shares of Stryker in the 2nd quarter valued at about $29,000. 77.09% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. Robert W. Baird set a $437.00 price target on Stryker in a research note on Friday, January 30th. Wells Fargo & Company boosted their price objective on Stryker from $452.00 to $456.00 and gave the company an “overweight” rating in a report on Friday, November 14th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $435.00 target price on shares of Stryker in a report on Friday, November 14th. Piper Sandler reissued an “overweight” rating on shares of Stryker in a research report on Tuesday, January 27th. Finally, Needham & Company LLC boosted their price target on shares of Stryker from $448.00 to $454.00 and gave the company a “buy” rating in a research note on Friday, January 30th. Twelve analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $426.56.

Stryker Price Performance

Shares of NYSE SYK opened at $360.19 on Thursday. The company has a market capitalization of $137.74 billion, a PE ratio of 42.88, a PEG ratio of 2.11 and a beta of 0.87. The company has a quick ratio of 1.21, a current ratio of 1.89 and a debt-to-equity ratio of 0.66. The stock’s 50 day moving average price is $358.84 and its 200-day moving average price is $371.11. Stryker Corporation has a twelve month low of $329.16 and a twelve month high of $404.87.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, topping analysts’ consensus estimates of $4.40 by $0.07. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The business had revenue of $7.17 billion for the quarter, compared to analyst estimates of $7.12 billion. During the same period last year, the company posted $4.01 earnings per share. Stryker’s quarterly revenue was up 11.4% compared to the same quarter last year. On average, equities analysts anticipate that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 30th. Investors of record on Tuesday, March 31st will be given a dividend of $0.88 per share. The ex-dividend date is Tuesday, March 31st. This represents a $3.52 annualized dividend and a yield of 1.0%. Stryker’s dividend payout ratio is presently 41.90%.

Insider Transactions at Stryker

In other Stryker news, CFO Preston Wendell Wells sold 165 shares of Stryker stock in a transaction dated Thursday, November 20th. The shares were sold at an average price of $365.88, for a total value of $60,370.20. Following the sale, the chief financial officer owned 6,694 shares of the company’s stock, valued at approximately $2,449,200.72. The trade was a 2.41% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CAO William E. Berry, Jr. sold 1,953 shares of the business’s stock in a transaction dated Friday, November 14th. The shares were sold at an average price of $365.49, for a total transaction of $713,801.97. Following the completion of the transaction, the chief accounting officer owned 2,833 shares in the company, valued at approximately $1,035,433.17. The trade was a 40.81% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 5.90% of the company’s stock.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.